In this issue:
Outcomes following HDT-ASCT for Hodgkin’s lymphoma
Rapid rituximab infusions
Temsirolimus vs.investigator’s choice in MCL
Testicular DLBCL: incidence/natural history/survival before & after
rituximab
Leukaemia and occupations in NZ
Drug cross-resistance and therapy-induced resistance
in CLL by enhanced ITRT
Vitamin C depletion/supplementation in AML and
myelodysplastic syndrome
Antitumour activity of forodesine in CLL
Imatinib for refractory, fibrotic chronic GVHD
CAPELAL: haemostasis during asparaginase
induction in adults
Outcomes for adolescents/young adults with ALL on
co-operative group protocols
Please login below to download this issue (PDF)